Results 141 to 150 of about 8,882 (195)

Palmoplantar-predominant bullous pemphigoid with acral purpuric lesions: An unusual presentation. [PDF]

JAAD Case Rep
Martínez Rozas L, Floristán Muruzábal MU, Pinedo-Moraleda FJ, Estebaranz JLL.   +3 more
europepmc   +1 more source

Linagliptin-Induced Bullous Pemphigoid: A Case Report and Comprehensive Literature Review. [PDF]

Cureus
Almutairi S, Alajmi FM, Albthali SM, Aldhafiri S.   +3 more
europepmc   +1 more source

The immunophenotype of immune checkpoint-induced bullous pemphigoid: a cohort study. [PDF]

Cancer Immunol Immunother
Saffuri N, Boyango I, Cohen I, Ali-Saleh Z, Dawood M, Khamaysi Z, Yogev D, Avitan-Hersh E.   +7 more
europepmc   +1 more source

Gliptin-Induced Bullous Pemphigoid: Are Statins and Angiotensin Receptor Blockers the Cause? [PDF]

Dermatol Ther (Heidelb)
Beksac B, Temirkaynak MK, Gharehdaghi S, Atesci E, Kubat G, Erdem O, Ilter N, Adisen E.   +7 more
europepmc   +1 more source

Genetically Predicted t⁶A (a tRNA-Derived Adenosine Modification) and Risk of Bullous Pemphigoid: A Two-Sample Mendelian Randomization Study. [PDF]

Clin Cosmet Investig Dermatol
Yan L, Chen D, Yu D, Shen X.
europepmc   +1 more source

Successful Treatment of Concurrent Bullous Pemphigoid and Psoriasis Vulgaris with Abrocitinib: A Case Report and Literature Review. [PDF]

Clin Cosmet Investig Dermatol
Hu YQ, Zhang JZ, Zhao Y.
europepmc   +1 more source

Dupilumab in patients with bullous pemphigoid and concomitant atopy. [PDF]

Front Pharmacol
Jobst K, Künzel SR, Beissert S, Abraham S.   +3 more
europepmc   +1 more source

Treatment of juvenile bullous pemphigoid with lebrikizumab. [PDF]

J Dtsch Dermatol Ges
Wittenberg M, Solimani F, Dilling A, Snobar R, Ghoreschi K, Klemp M, Kusch K.   +6 more
europepmc   +1 more source

Successful management of DPP-4 inhibitor-induced bullous pemphigoid with Stapokibart injection in an elderly diabetic patient: a case report. [PDF]

Front Med (Lausanne)
Yu M, Tian S, Meng F.
europepmc   +1 more source

Antituberculous Therapy-Induced Rare Skin Toxicity: Bullous Pemphigoid.

J Pharm Bioallied Sci
Patil RC, Krishnamurthy V, Prabhu D, Kumar SP.   +3 more
europepmc   +1 more source